by It appears pertuzumab, when used along side Trastuzumab and chemotherapy, improves the rates of invasive-disease-free survival among patients with early stage, HER2-positive breast cancer.
Amir Isbell
Amir Isbell
It appears pertuzumab, when used along side Trastuzumab and chemotherapy, improves the rates of invasive-disease-free survival among patients with early stage, HER2-positive breast cancer.